Data / Research funding / Tuberculosis Vaccine

Tuberculosis Vaccine: 127 NIH awards ($584.7M) to 59 organizations

Name: NIH and NSF awards on Tuberculosis Vaccine
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

127 NIH awards ($584.7M) in the NIH spending category Tuberculosis Vaccine, to 59 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Tuberculosis Vaccine Watch Tuberculosis Vaccine

Topic: NIH spending category

Awards

127 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
HIV Vaccines Clinical Trials Network Leadership and Operations Center	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$244,071,463	June 29, 2006	November 30, 2027	COREY, LAWRENCE	reporter.nih.gov
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$61,029,344	September 30, 2019	March 31, 2027	URDAHL, KEVIN	reporter.nih.gov
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$38,435,039	September 30, 2019	September 29, 2026	FORTUNE, SARAH	reporter.nih.gov
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$35,184,139	August 1, 2021	July 31, 2026	COLER, RHEA	reporter.nih.gov
Vaccine and Treatment Evaluation Unit at Saint Louis University	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$21,219,564	December 11, 2019	November 30, 2026	HOFT, DANIEL F.	reporter.nih.gov
Development of an Optimized Adjuvanted TB Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2024	$11,645,061	September 30, 2021	September 30, 2025	EVANS, JAY	reporter.nih.gov
Advancing Vaccine Adjuvant Research for Tuberculosis (TB)	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$10,964,476	September 30, 2022	September 29, 2027	BRITTON, WARWICK	reporter.nih.gov
DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$9,566,206	September 30, 2023	September 29, 2026	EVANS, JAY	reporter.nih.gov
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$6,398,428	July 1, 2021	June 30, 2027	GENGENBACHER, MARTIN ALFONS	reporter.nih.gov
Preventing TB with intravenous BCG in SIV-infected macaques	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$4,248,442	May 5, 2021	April 30, 2026	SCANGA, CHARLES A.	reporter.nih.gov
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$4,208,331	June 1, 2020	July 31, 2030	SESHADRI, CHETAN	reporter.nih.gov
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$4,152,012	February 1, 2023	January 31, 2027	KHADER, SHABAANA A.	reporter.nih.gov
A STINGing vaccine for TB	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2024	$4,090,805	June 1, 2020	May 31, 2026	BISHAI, WILLIAM RAMSES	reporter.nih.gov
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$3,876,556	March 15, 2021	February 28, 2027	HORWITZ, MARCUS AARON	reporter.nih.gov
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$3,714,524	September 30, 2025	September 29, 2026	ESSER-KAHN, AARON	reporter.nih.gov
Identification of Novel Syk/Raf-1 Mediated CLR Ligands as Vaccine Adjuvants	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$3,198,798	September 30, 2025	September 29, 2026	EVANS, JAY	reporter.nih.gov
Enhancing cytotoxic lymphocytes in a TB vaccine strategy	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$3,037,076	February 25, 2022	January 31, 2027	FLYNN, JOANNE L.	reporter.nih.gov
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2024	$3,027,518	March 17, 2020	February 28, 2025	KARAKOUSIS, PETROS C	reporter.nih.gov
Mechanisms of CD4 T cell help to myeloid cells in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$2,863,501	August 1, 2025	July 31, 2029	BOLD, TYLER DALLAS	reporter.nih.gov
Adjuvant Development in the context of a vaccine to protect against tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,722,493	September 30, 2018	September 29, 2023	PETROVSKY, NIKOLAI	reporter.nih.gov
Regulation of innate immunity by self-adjuvated MRNA vaccines	NIH	National Institute of Allergy and Infectious Diseases	2025	$2,710,680	August 12, 2025	May 31, 2029	JAGANNATH, CHINNASWAMY	reporter.nih.gov
Th9 cells and protective TB immunity	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$2,670,376	March 9, 2022	February 28, 2027	HOFT, DANIEL F.	reporter.nih.gov
Lung immune function in human TB infection and its perturbation by HIV-1.	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2024	$2,627,712	June 4, 2020	May 31, 2025	RUSSELL, DAVID G	reporter.nih.gov
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$2,540,587	July 1, 2023	June 30, 2028	ERNST, JOEL D.	reporter.nih.gov
Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,406,319	December 1, 2017	November 30, 2025	HORWITZ, MARCUS AARON	reporter.nih.gov
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$2,404,290	July 20, 2023	June 30, 2028	SCANGA, CHARLES A.	reporter.nih.gov
Development of a Self Inactivating, Highly Effective TB Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,381,016	February 6, 2019	January 31, 2024	FLYNN, JOANNE L.	reporter.nih.gov
Molecular Genetic Analysis of Mycobacterium Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$2,368,749	December 1, 1988	August 31, 2028	JACOBS, WILLIAM ROBERT	reporter.nih.gov
Characteristics and protective efficacy of human antibodies against M. tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,338,122	July 1, 2019	June 30, 2025	ACHKAR, JACQUELINE MICHELE	reporter.nih.gov
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$2,322,288	July 9, 2024	May 31, 2029	KAUSHAL, DEEPAK	reporter.nih.gov
Durability of systemic and lung immune correlates of BCG-induced protection against M. tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$2,311,437	August 11, 2020	July 31, 2026	NEMES, ELISA	reporter.nih.gov
Role of IL-17 in Protective Vaccine-induced Immune Responses Against Tuberculosis	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,302,219	December 15, 2010	July 31, 2026	KHADER, SHABAANA A.	reporter.nih.gov
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,298,018	December 15, 2017	November 30, 2023	MALLEY, RICHARD	reporter.nih.gov
Mechanisms of vitamin A-dependent risk for tuberculosis progression and prevention	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$2,246,313	June 15, 2023	May 31, 2028	PODELL, BRENDAN	reporter.nih.gov
Defining the antibody interface between Mycobacterium tuberculosis and host immunity	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$2,063,021	September 23, 2021	August 31, 2027	LU, LENETTE	reporter.nih.gov
Immunotherapeutic approach for the prevention of secondary infection with drug-resistant TB	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,956,687	June 13, 2024	April 30, 2029	COLER, RHEA N	reporter.nih.gov
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,803,446	December 1, 2017	November 30, 2023	MORTENSEN, RASMUS SKAARUP	reporter.nih.gov
Targeting trained immunity and Th1/Th17 axis with combination adjuvants	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$1,799,999	July 26, 2021	April 30, 2027	KHADER, SHABAANA A.	reporter.nih.gov
Multivalent DNA vaccine-mediated protection against Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,773,692	November 23, 2017	October 31, 2024	WEINER, DAVID B.	reporter.nih.gov
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$1,770,744	July 1, 2023	June 30, 2028	BOLD, TYLER DALLAS	reporter.nih.gov
Optimizing vaccine science to improve the outcome of tuberculosis treatment	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$1,751,227	June 17, 2021	May 31, 2027	SUBBIAN, SELVAKUMAR	reporter.nih.gov
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,745,052	May 17, 2018	April 30, 2025	KAUSHAL, DEEPAK	reporter.nih.gov
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,676,215	September 9, 2020	September 2, 2022	KHADER, SHABAANA A.	reporter.nih.gov
RNA Vaccine Innovations for TB: Targeting the Mucosa	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$1,632,094	April 22, 2022	September 30, 2025	REED, STEVEN GREGORY	reporter.nih.gov
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$1,615,572	May 10, 2022	April 30, 2026	BEAMER, GILLIAN L	reporter.nih.gov
Mechanisms of IFNg-independent T cell and B cell-mediated protection in TB.	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,569,789	August 26, 2024	June 30, 2029	SALGAME, PADMINI	reporter.nih.gov
Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,544,840	July 1, 2024	June 30, 2029	PHILIPS, JENNIFER A	reporter.nih.gov
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,522,818	August 1, 2019	July 31, 2025	SCOTT, EVAN ALEXANDER	reporter.nih.gov
Ontogeny and metabolism of lung alveolar macrophages in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,503,349	August 13, 2024	July 31, 2029	HUANG, LU	reporter.nih.gov
Ultrasensitive detection of Mycobacterium tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,461,934	July 22, 2024	June 30, 2029	CIRILLO, JEFFREY D.	reporter.nih.gov
Novel Nanoparticle Respiratory Tract Mucosal Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$1,426,482	April 1, 2022	March 31, 2025	QUINN, FREDERICK D	reporter.nih.gov
Optimizing vaccine science to improve the outcome of tuberculosis treatment	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,409,583	June 17, 2021	May 31, 2023	SUBBIAN, SELVAKUMAR	reporter.nih.gov
Regulation of CD8+ T cell immunity to tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,409,160	August 2, 2013	April 30, 2024	BEHAR, SAMUEL M	reporter.nih.gov
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$1,392,562	April 1, 2022	March 31, 2025	LOVELL, JONATHAN F	reporter.nih.gov
A novel hyper-immunogenic low virulent BCG vaccine against tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$1,373,187	February 3, 2023	April 20, 2025	DHANDAYUTHAPANI, SUBRAMANIAN	reporter.nih.gov
Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$1,336,253	May 20, 2022	March 31, 2025	POSTLER, THOMAS SIEGMUND	reporter.nih.gov
BCG overexpressing a small molecule STING agonist as a vaccine for TB	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,261,288	June 20, 2024	July 31, 2028	WALLACH, TODD	reporter.nih.gov
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,184,815	May 14, 2018	April 30, 2025	WANG, CHYUNG-RU	reporter.nih.gov
Targeting trained immunity and Th1/Th17 axis with combination adjuvants	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,167,749	July 26, 2021	September 1, 2022	KHADER, SHABAANA A.	reporter.nih.gov
Oral BCG: Optimizing mucosal vaccination against tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$1,162,224	April 24, 2025	March 31, 2030	LIN, PHILANA LING	reporter.nih.gov
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,133,140	February 1, 2019	January 31, 2024	LEWINSOHN, DAVID M.	reporter.nih.gov
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,083,318	May 1, 2018	April 30, 2024	CHAN, JOHN R.	reporter.nih.gov
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2025	$1,067,980	March 1, 2023	August 31, 2027	KHADER, SHABAANA A.	reporter.nih.gov
Determinants of antigen specific CD4 T cell function in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$1,006,392	April 1, 2021	September 30, 2026	BOLD, TYLER DALLAS	reporter.nih.gov
TOLLIP Deficiency, Immune Dysregulation, and Tuberculosis Susceptibility	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,003,164	March 1, 2018	February 29, 2024	SHAH, JAVEED ALI	reporter.nih.gov
Live nasal recombinant B. pertussis vaccine against tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$972,074	May 4, 2022	March 31, 2026	GOLDSTEIN, PETER	reporter.nih.gov
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$955,150	April 1, 2022	May 31, 2027	LOVELL, JONATHAN F	reporter.nih.gov
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$952,443	March 1, 2023	February 28, 2026	KHADER, SHABAANA A.	reporter.nih.gov
Influence of SIV replication on TB progression and immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$945,816	June 26, 2017	May 31, 2023	AMBROSE, ZANDREA	reporter.nih.gov
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021	$915,731	May 22, 2020	September 30, 2022	KHADER, SHABAANA A.	reporter.nih.gov
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023	$914,044	September 9, 2020	August 31, 2025	KHADER, SHABAANA A.	reporter.nih.gov
Evaluating the safety, immunogenicity and efficacy of a robust attenuated Mtb vaccine in the setting of HIV co-infection	NIH	National Institute of Allergy and Infectious Diseases	2025	$905,998	June 17, 2025	May 31, 2030	KAUSHAL, DEEPAK	reporter.nih.gov
A Neonatal Monkey Model of Tuberculosis Vaccination	NIH	National Institute of Allergy and Infectious Diseases	2021	$893,080	June 1, 2019	May 31, 2023	JAGANNATH, CHINNASWAMY	reporter.nih.gov
Immune Correlates of Protection from TB	NIH	National Institute of Allergy and Infectious Diseases	2022	$889,259	July 1, 2017	June 30, 2024	KAUSHAL, DEEPAK	reporter.nih.gov
PROTECTIVE CD8 T CELL RESPONSES to TUBERCULOSIS	NIH	National Institute of Allergy and Infectious Diseases	2025	$832,076	August 8, 2025	July 31, 2030	BEHAR, SAMUEL M	reporter.nih.gov
Evaluating human T cells specific for Mycobacterium tuberculosis antigens that are processed and presented by infected macrophages	NIH	National Institute of Allergy and Infectious Diseases	2025	$813,450	August 1, 2025	July 31, 2030	CARPENTER, STEPHEN MATTHEW	reporter.nih.gov
Determining Protective Features of Human Memory T-cells to Inform Mycobacterium tuberculosis Vaccine Development	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$773,280	August 11, 2022	July 31, 2027	CARPENTER, STEPHEN MATTHEW	reporter.nih.gov
Novel Nanoparticle Respiratory Tract Mucosal Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2025	$763,709	April 1, 2022	July 31, 2027	QUINN, FREDERICK D	reporter.nih.gov
Molecular basis of BCG vaccine sub-strain heterogeneity	NIH	National Institute of Allergy and Infectious Diseases	2025	$749,192	November 22, 2024	October 31, 2029	CIRILLO, JEFFREY D.	reporter.nih.gov
HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$734,192	September 4, 2019	August 31, 2024	JOOSTEN, SIMONE ANNE	reporter.nih.gov
Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$700,469	May 20, 2022	May 31, 2027	POSTLER, THOMAS SIEGMUND	reporter.nih.gov
Dissecting the role of vaccine-promoted Th17 cells in protective immunity against tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$666,567	August 19, 2025	July 31, 2030	MORTENSEN, RASMUS SKAARUP	reporter.nih.gov
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings	NIH	National Institute of Allergy and Infectious Diseases	2021	$660,785	August 22, 2017	July 31, 2023	URDAHL, KEVIN B	reporter.nih.gov
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB	NIH	National Institute of Allergy and Infectious Diseases	2021	$648,004	June 20, 2017	May 31, 2022	RENGARAJAN, JYOTHI	reporter.nih.gov
A novel quadruple knockout MTb vaccine against tuberculosis (Supplement Resubmission)	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$626,202	June 8, 2021	May 31, 2025	DHANDAYUTHAPANI, SUBRAMANIAN	reporter.nih.gov
Estimating the Epidemiologic Impact of TB Vaccines using Mathematical Models	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$599,924	August 18, 2022	July 31, 2027	NELSON, KRISTIN NICOLE BRATTON	reporter.nih.gov
Therapeutic vaccine platform to boost immune responses in Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$599,471	August 1, 2025	July 31, 2027	ANTHONY, KAREN G.	reporter.nih.gov
Immunometabolic signatures of BCG-induced neonatal trained immunity	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2025	$528,634	July 6, 2023	June 30, 2028	ANGELIDOU, ASIMENIA	reporter.nih.gov
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021	$506,563	May 1, 2018	September 15, 2021	CHAN, JOHN R.	reporter.nih.gov
Conditionally replicating Mycobacterium tuberculosis vaccines	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$479,204	September 1, 2018	August 31, 2024	EHRT, SABINE	reporter.nih.gov
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2022	$467,889	March 1, 2022	September 1, 2022	KHADER, SHABAANA A.	reporter.nih.gov
The impact of IL-4 and IL-4-producing cells on protective immunity to tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$464,662	December 8, 2023	October 31, 2025	BEHAR, SAMUEL M	reporter.nih.gov
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$456,550	March 21, 2023	February 28, 2026	SHAH, JAVEED ALI	reporter.nih.gov
High-Throughput TB Vaccine Antigen Discovery	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$454,497	June 1, 2019	August 31, 2024	MARTINOT, AMANDA	reporter.nih.gov
A novel c-di-AMP-based recombinant BCG vaccine	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$448,250	February 9, 2023	January 31, 2026	BAI, GUANGCHUN	reporter.nih.gov
The human lung and lung-draining lymph node response to Mycobacterium tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$433,592	January 12, 2023	December 31, 2024	ROY CHOWDHURY, ROSHNI	reporter.nih.gov
Epigenetic Study of Resistance to Infection by Mycobacterium tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$430,188	June 8, 2021	May 31, 2025	SUN, YAN	reporter.nih.gov
Novel multivalent viral vectored tuberculosis vaccines targeting lung immunity	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$416,946	June 23, 2023	May 31, 2025	TISCHLER, ANNA DEGRAFF	reporter.nih.gov
Mechanisms of a therapeutic DNA vaccine targeting Mycobacterium tuberculosis persisters	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$401,760	December 11, 2023	November 30, 2028	KARANIKA, STYLIANI	reporter.nih.gov
Mycobacterial determinants of escape from pathogen-specific immunity	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$397,440	June 14, 2018	May 31, 2023	CAREY, ALLISON	reporter.nih.gov
Live Imaging of Immunity to M. tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$390,866	January 6, 2021	December 31, 2023	ERNST, JOEL D.	reporter.nih.gov
A novel approach to determine the value of ESAT-6 as an antigen in M. tuberculosis infection and vaccines	NIH	National Institute of Allergy and Infectious Diseases	2025	$278,390	February 1, 2025	January 31, 2027	ERNST, JOEL D.	reporter.nih.gov
Effect of Community Wide Deworming on Hookworm Modulated Immune Responses to Bystander Antigens and Vaccines in Southern India	NIH	Fogarty International Center	2021 to 2024	$276,148	February 28, 2020	January 31, 2025	AJJAMPUR, SITARA SWARNA RAO	reporter.nih.gov
A whole-cell inactivated vaccine for improved protection against tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$269,874	August 1, 2025	July 31, 2027	ARTINGER, MICHAEL	reporter.nih.gov
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$249,000	August 1, 2023	August 31, 2027	DUTT, TARU S.	reporter.nih.gov
Acellular TB vaccines adjuvanted with BcfA	NIH	National Institute of Allergy and Infectious Diseases	2021	$234,000	March 5, 2020	February 28, 2023	DUBEY, PURNIMA	reporter.nih.gov
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$224,722	August 1, 2023	July 31, 2025	DUTT, TARU S.	reporter.nih.gov
Early T cell responses in tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2025	$209,408	September 19, 2025	August 31, 2030	SIMONSON, ANDREW WILLIAM	reporter.nih.gov
The Role of SLAMF1 in TB Immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$196,875	June 1, 2020	May 31, 2023	PHILIPS, JENNIFER A	reporter.nih.gov
Role of molecular drivers in memory group 1 CD1-restricted T cell differentiation and Mycobacterium tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2024	$195,960	September 15, 2021	August 31, 2025	MORGUN, EVA	reporter.nih.gov
Cross development of surrogate efficacy mycobacterial growth inhibition assay endpoint for the translational guinea pig model	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$195,700	May 16, 2024	March 31, 2026	COLER, RHEA N	reporter.nih.gov
Mucosal Adjuvant to Induce Multipronged T Cell Immunity to Tuberculosis	NIH	National Institute of Allergy and Infectious Diseases	2021	$194,167	March 12, 2020	August 31, 2022	SURESH, MARULASIDDAPPA	reporter.nih.gov
Interferon gamma-dependent immunity to Mycobacterium tuberculosis mediated by regulation of inflammation by lung macrophages	NIH	National Institute of Allergy and Infectious Diseases	2025	$188,760	September 1, 2025	August 31, 2030	MACIAG, KAROLINA	reporter.nih.gov
Host genetic diversity, T cell responses, and outcomes of TB	NIH	National Institute of Allergy and Infectious Diseases	2021	$181,165	September 1, 2020	August 31, 2023	ERNST, JOEL D.	reporter.nih.gov
Host genetic diversity, mononuclear phagocytes, and outcomes of TB	NIH	National Institute of Allergy and Infectious Diseases	2021	$161,500	June 16, 2020	May 30, 2022	ERNST, JOEL D.	reporter.nih.gov
Mechanistic investigation of differential T cell responses to distinct Mycobacterium tuberculosis antigens	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2024	$131,910	July 1, 2022	June 30, 2025	HOWARD, ZACHARY	reporter.nih.gov
The role of antigen-independent T cell activation in controlling M. tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$98,512	February 1, 2024	January 31, 2027	WINTER, CASSANDRA	reporter.nih.gov
Investigating the role of gamma delta (γδ) T cells in the control of Mycobacterium tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$98,512	August 1, 2024	July 31, 2027	TAPPEN, VICTORIA	reporter.nih.gov
Development of Small Molecule Probes for the Selective Modification and Labeling of the Mycobacterial Cell Wall	NIH	National Institute of General Medical Sciences	2021 to 2022	$85,245	April 6, 2021	June 30, 2022	KIM, DARIA ELDAROVNA	reporter.nih.gov
Impact of Mycobacterium tuberculosis on monocyte differentiation in vivo	NIH	National Heart, Lung, and Blood Institute	2023	$80,928	February 1, 2023	January 31, 2024	MOHAPATRA, ALEXANDER	reporter.nih.gov
The impact of two-pore channel calcium signaling on MR1 antigen presentation of Mycobacterium tuberculosis metabolites	NIH	National Institute of Allergy and Infectious Diseases	2025	$49,538	September 1, 2025	August 31, 2027	TAMMEN, ALLISON	reporter.nih.gov
Elucidating the mechanism and correlates of protection elicited by CDN adjuvanted vaccines for M. tuberculosis.	NIH	National Institute of Allergy and Infectious Diseases	2025	$48,395	November 1, 2025	June 30, 2027	LAMB-ECHEGARAY, ISABEL	reporter.nih.gov
Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection	NIH	National Institute of Allergy and Infectious Diseases	2021	$39,793	April 1, 2020	April 2, 2021	IZZO, ANGELO A	reporter.nih.gov
Exploiting Fc-engineering to dissect mechanisms of anti-microbial action of M. tuberculosis-specific antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021	$32,020	September 1, 2020	July 5, 2022	IRVINE, EDWARD BUFORD	reporter.nih.gov
Infectious Diseases in Africa: Correlates of Protection, Lessons from Vaccines and Natural Infection Studies	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$25,001	March 3, 2020	February 28, 2023	FERRARI, GUIDO	reporter.nih.gov
6th Global Forum on TB Vaccines	NIH	National Institute of Allergy and Infectious Diseases	2021	$6,500	April 16, 2021	March 31, 2022	FREVOL, AUDE	reporter.nih.gov
Tuberculosis: Heterogeneity from Experimental Models to Human Disease	NIH	National Institute of Allergy and Infectious Diseases	2025	$6,500	January 23, 2025	December 31, 2025	SHEPPARD, TERRY L.	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
Fred Hutchinson Cancer Center	Seattle, WA	1	$244.1 million	$0
Seattle Children's Hospital	Seattle, WA	5	$99 million	$0
Harvard University D/b/a Harvard School of Public Health	Boston, MA	2	$38.5 million	$0
University of Montana	Missoula, MT	3	$24.4 million	$0
Saint Louis University	Saint Louis, MO	2	$23.9 million	$0
University of Chicago	Chicago, IL	8	$15.3 million	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	7	$14.4 million	$0
University of Sydney	Sydney	1	$11 million	$0
Johns Hopkins University	Baltimore, MD	3	$7.5 million	$0
Texas Biomedical Research Institute	San Antonio, TX	5	$7.5 million	$0
Hackensack University Medical Center	Hackensack, NJ	1	$6.4 million	$0
University of California Los Angeles	Los Angeles, CA	2	$6.3 million	$0
University of Minnesota	Minneapolis, MN	4	$6.1 million	$0
University of Washington	Seattle, WA	6	$6.1 million	$0
Washington University	Saint Louis, MO	6	$6 million	$0
Albert Einstein College of Medicine	Bronx, NY	3	$5.2 million	$0
University of California, San Francisco	San Francisco, CA	7	$3.8 million	$0
Methodist Hospital Research Institute	Houston, TX	2	$3.6 million	$0
Rutgers Biomedical and Health Sciences	Newark, NJ	2	$3.3 million	$0
Vaxine Pty LTD	Bedford Park	1	$2.7 million	$0
Univ of Massachusetts Med SCH Worcester	Worcester, MA	3	$2.7 million	$0
Cornell University	Ithaca, NY	1	$2.6 million	$0
Colorado State University	Fort Collins, CO	3	$2.5 million	$0
Rbhs-New Jersey Medical School	Newark, NJ	2	$2.5 million	$0
Statens Serum Institute	Copenhagen	2	$2.5 million	$0
SUNY at Buffalo	Amherst, NY	2	$2.3 million	$0
University of Cape Town	Rondebosch	1	$2.3 million	$0
Boston Children's Hospital	Boston, MA	1	$2.3 million	$0
Texas A&m University Health Science CTR	College Station, TX	2	$2.2 million	$0
University of Georgia Research Foundation Inc	Athens, GA	2	$2.2 million	$0
Ut Southwestern Medical Center	Dallas, TX	1	$2.1 million	$0
International Aids Vaccine Initiative	New York, NY	3	$2 million	$0
Texas Tech University Health Sciences Center at El Paso	El Paso, TX	2	$2 million	$0
Wistar Institute	Philadelphia, PA	1	$1.8 million	$0
Emory University	Atlanta, GA	3	$1.7 million	$0
HDT Bio Corporation	Seattle, WA	1	$1.6 million	$0
Case Western Reserve University	Cleveland, OH	2	$1.6 million	$0
Northwestern University	Chicago, IL	1	$1.5 million	$0
Univ of Arkansas for Med Scis	Little Rock, AR	1	$1.5 million	$0
Northwestern University at Chicago	Chicago, IL	2	$1.4 million	$0
Oncosting LLC	Baltimore, MD	1	$1.3 million	$0
Oregon Health & Science University	Portland, OR	2	$1.2 million	$0
Iliad Biotechnologies, LLC	New York, NY	1	$972,074	$0
Leiden University Medical Center	Leiden	1	$734,192	$0
L2 Diagnostics, LLC	New Haven, CT	1	$599,471	$0
Beth Israel Deaconess Medical Center	Boston, MA	1	$528,634	$0
Weill Medical Coll of Cornell Univ	New York, NY	1	$479,204	$0
Tufts University Boston	Boston, MA	1	$454,497	$0
Albany Medical College	Albany, NY	1	$448,250	$0
University of Utah	Salt Lake City, UT	1	$397,440	$0
Christian Medical College	Vellore	1	$276,148	$0
Solaris Vaccines, Inc.	Fort Collins, CO	1	$269,874	$0
University of Alabama at Birmingham	Birmingham, AL	1	$249,000	$0
Ohio State University	Columbus, OH	1	$234,000	$0
University of Wisconsin-Madison	Madison, WI	1	$194,167	$0
Massachusetts Institute of Technology	Cambridge, MA	1	$85,245	$0
University of California-Berkeley	Berkeley, CA	1	$48,395	$0
Duke University	Durham, NC	1	$25,001	$0
Keystone Symposia	Silverthorne, CO	1	$6,500	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	64	$90,612,134	$0
2024	62	$100,434,835	$0
2023	53	$130,296,367	$0
2022	58	$197,346,446	$0
2021	55	$66,046,376	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)	PA-24-182	NIH		May 8, 2027	Not listed	Notice number printed on 1 award here
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)	RFA-AI-27-002	NIH	93.855	November 10, 2026	Not listed	Same assistance listing 93.855 as 113 awards here
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)	RFA-AI-27-005	NIH	93.855	November 10, 2026	Not listed	Same assistance listing 93.855 as 113 awards here
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)	PAR-25-370	NIH	93.855	November 16, 2026	$50,000	Same assistance listing 93.855 as 113 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.855	November 18, 2026	Not listed	Same assistance listing 93.855 as 113 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.855	November 18, 2026	Not listed	Same assistance listing 93.855 as 113 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.855	January 7, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
HIV/AIDS Clinical Trials Network Leadership and Operations Centers	RFA-AI-28-001	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
HIV/AIDS Clinical Trials Network Laboratory Centers	RFA-AI-28-002	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
HIV/AIDS Clinical Trials Network Statistical and Data Management Centers	RFA-AI-28-003	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
HIV/AIDS Clinical Trials Network Clinical Trials Units	RFA-AI-28-004	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases	RFA-AI-28-014	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
Immune Tolerance Network (UM1 Clinical Trial Required)	RFA-AI-28-005	NIH	93.855	January 29, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)	RFA-AI-28-012	NIH	93.855	January 29, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)	RFA-AI-28-024	NIH	93.855	February 11, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)	RFA-LM-28-001	NIH	93.855	February 11, 2027	$775,000	Same assistance listing 93.855 as 113 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.855	April 5, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.855	April 5, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 113 awards here
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)	PA-24-185	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 113 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.